Arkolith/Insider Trading/CRBP/Form 4

Moran Sean F.

Chief Financial OfficerCorbus Pharmaceuticals Holdings, Inc. (CRBP) · full profile →Form 4 · filed Oct 27, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$221K
Net Open-Market Flow
-$221K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 24, 2025Sell(S)13K$17.02$221K73K
Oct 24, 2025Option exercise(M)13K$4.26$55K86K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 24, 2025Option exercise(M)13K—$010K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-251635) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML